These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of Miao Y; Feng R; Yu T; Guo R; Zhang M; Wang Y; Hai W; Shangguan C; Zhu Z; Li B J Nucl Med; 2024 Feb; 65(2):213-220. PubMed ID: 38164574 [TBL] [Abstract][Full Text] [Related]
3. Initial Results of Backhaus P; Burg MC; Asmus I; Pixberg M; Büther F; Breyholz HJ; Yeh R; Weigel SB; Stichling P; Heindel W; Bobe S; Barth P; Tio J; Schäfers M J Nucl Med; 2023 May; 64(5):717-723. PubMed ID: 36396458 [TBL] [Abstract][Full Text] [Related]
4. Comparison of [ Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma. Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976 [TBL] [Abstract][Full Text] [Related]
7. Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276 [TBL] [Abstract][Full Text] [Related]
8. The role of [ Civan C; Kuyumcu S; Has Simsek D; Sanli O; Isik EG; Ozkan ZG; Hurdogan O; Sanli Y Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):852-861. PubMed ID: 37803246 [TBL] [Abstract][Full Text] [Related]
9. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571 [TBL] [Abstract][Full Text] [Related]
10. Clinical Evaluation of Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial. Bentestuen M; Ladekarl M; Knudsen A; Zacho HD BMC Cancer; 2024 Jun; 24(1):699. PubMed ID: 38849741 [TBL] [Abstract][Full Text] [Related]
12. Head-to-head comparison of [ Ji M; Ma G; Liu C; Gu B; Du X; Ou X; Xu X; Song S; Yang Z Cancer Imaging; 2024 May; 24(1):56. PubMed ID: 38702821 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Baseline Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263 [TBL] [Abstract][Full Text] [Related]
15. Role of Akimoto E; Kadoya T; Kajitani K; Emi A; Shigematsu H; Ohara M; Masumoto N; Okada M Clin Breast Cancer; 2018 Feb; 18(1):45-52. PubMed ID: 28993056 [TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography and computed tomography with [ Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226 [TBL] [Abstract][Full Text] [Related]
18. The potential utility of [ Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435 [TBL] [Abstract][Full Text] [Related]
19. [ Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of [ Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603 [TBL] [Abstract]